Introduction Pelvic exenteration (PE) is now the standard of care for locally advanced
(LARC) and locally recurrent (LRRC) rectal cancer. Reports of the significant short-term …

Pelvic exenteration was first described by Alexander Brunschwig in 1948 in New York as a
palliative procedure for recurrent carcinoma of the cervix. Because of initially high rates of …

PURPOSE: This retrospective study identifies the clinicopathologic factors (age, gender, size
of tumor, location, tumor stage, lymph node metastasis, histologic differentiation, and …

BACKGROUND: Patients with stage T4 rectal cancer are known to have poor survival and
often require pelvic exenteration (PE). We describe the oncologic outcome of PE for patients …

The treatment of rectal cancer typically involves a multidisciplinary approach. A minority of
patients will have tumors that are full thickness, involve adjacent structures, or have …

Objective To investigate the outcome of surgical treatment for patients with T4 rectal cancer
and to evaluate prognostic factors influencing 5‐year disease‐free survival. Patients Of 1600 …

Background The postoperative and survival outcomes of patients with primary advanced
colorectal cancer who undergo partial versus total cystectomy have not been adequately …

Abstract Background and Objectives It is not uncommon for colorectal carcinomas to invade
the urinary bladder. However, the actual incidence of urinary bladder invasion of colorectal …

OBJECTIVES: To review cases of colorectal cancer requiring urologic management to clarify
the role the urologist should play in the surgical procedures. A deterrent to radical surgery …

Purpose Total pelvic exenteration (TPE) is the standard procedure for locally advanced
rectal cancer involving the prostate and seminal vesicles. We evaluated the feasibility of …